Oxford Nanopore
Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments â MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.
Oxford Nanopore Facts
CEO: Gordon Sanghera
Website: www.nanoporetech.com
Ticker symbol: Privately held
Headquarters: Oxford, UK
Number of employees: 250+
Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle
Oracle and Oxford Nanopore will also collaborate on integrating sequencing data with Oracle's cloud computing infrastructure and life sciences solutions.
Speedy Long-Read Genome Assembly Enabled by Minimizer-Space Analysis
The minimizer-space de Bruijn graph approach could assemble a human genome in less than 10 minutes using eight cores and 10 gigabytes of random access memory.
Oxford Nanopore Technologies Registers for IPO on London Stock Exchange
For the first half of 2021, life science research tools (LSRT) revenues more than doubled year over year while COVID testing revenues declined 72 percent.
Trading Plans
Reuters reports that Oxford Nanopore has released plans to be traded on the London stock exchange.